Analyzing renal biopsies from patients with prominent podocyte damage such as in MCD, FSGS, MGN and amyloidosis, we report significant upregulation of podocyte CD73 expression in each of these groups in comparison to control kidneys, independent of the etiology of the podocyte damage. This evidence concerns the gene NT5E and focal segmental glomerulosclerosis.